Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningitidis Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00444951
What this trial is testing

Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia

Who this might be right for
Neisseria MeningitidisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 450
Testing effectiveness (Phase 2)Study completedNCT00269477
What this trial is testing

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 145
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Large-scale testing (Phase 3)Study completedNCT01934140
What this trial is testing

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Who this might be right for
Infections, Meningococcal
Pfizer 311
Large-scale testing (Phase 3)Study completedNCT00661713
What this trial is testing

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

Who this might be right for
Meningococcal Disease
Novartis Vaccines 1,631
Large-scale testing (Phase 3)Study completedNCT00327184
What this trial is testing

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 709
Large-scale testing (Phase 3)Study completedNCT01235975
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 400
Large-scale testing (Phase 3)Study completedNCT00586612
What this trial is testing

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 313
Testing effectiveness (Phase 2)Study completedNCT00291967
What this trial is testing

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
GlaxoSmithKline 525
Testing effectiveness (Phase 2)Study completedNCT00258856
What this trial is testing

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 234
Large-scale testing (Phase 3)Study completedNCT01767376
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 692
Post-approval studies (Phase 4)Study completedNCT00290329
What this trial is testing

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 249
Testing effectiveness (Phase 2)Study completedNCT01090453
What this trial is testing

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 480
Not applicableStudy completedNCT01730391
What this trial is testing

Neisseria Meningitidis Burden of Disease Study

Who this might be right for
Streptococcus PneumoniaeNeisseria MeningitidisHaemophilus Influenzae
GlaxoSmithKline 521
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Large-scale testing (Phase 3)Study completedNCT00359983
What this trial is testing

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 270
Post-approval studies (Phase 4)Study completedNCT01766206
What this trial is testing

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea

Who this might be right for
Meningococcal Disease
GlaxoSmithKline 3,948
Testing effectiveness (Phase 2)Study completedNCT00471081
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 385
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Next Page